STAAR Surgical (NASDAQ:STAA) Major Shareholder Broadwood Partners, L.P. Acquires 93,124 Shares

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. acquired 93,124 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was purchased at an average price of $17.54 per share, for a total transaction of $1,633,394.96. Following the completion of the purchase, the insider now directly owns 12,074,275 shares in the company, valued at $211,782,783.50. This trade represents a 0.78 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, March 20th, Broadwood Partners, L.P. purchased 108,720 shares of STAAR Surgical stock. The stock was acquired at an average cost of $17.96 per share, for a total transaction of $1,952,611.20.
• On Monday, March 3rd, Broadwood Partners, L.P. acquired 249,503 shares of STAAR Surgical stock. The stock was acquired at an average cost of $16.64 per share, with a total value of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. bought 259,316 shares of STAAR Surgical stock. The shares were acquired at an average cost of $17.05 per share, for a total transaction of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. purchased 36,532 shares of STAAR Surgical stock. The stock was bought at an average cost of $15.49 per share, with a total value of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. acquired 259,616 shares of STAAR Surgical stock. The shares were bought at an average cost of $14.96 per share, for a total transaction of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. bought 8,221 shares of STAAR Surgical stock. The shares were bought at an average cost of $21.50 per share, with a total value of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. purchased 21,155 shares of STAAR Surgical stock. The stock was purchased at an average cost of $21.46 per share, for a total transaction of $453,986.30.

STAAR Surgical Trading Down 1.1 %

STAA opened at $17.72 on Friday. The stock has a market capitalization of $874.04 million, a P/E ratio of -43.22 and a beta of 0.66. The stock has a 50-day moving average price of $19.87 and a 200-day moving average price of $25.66. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $52.68.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Mizuho lowered shares of STAAR Surgical from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $45.00 to $17.00 in a report on Wednesday, February 12th. Jefferies Financial Group cut shares of STAAR Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, February 12th. Needham & Company LLC reissued a “hold” rating on shares of STAAR Surgical in a research note on Thursday, February 27th. BTIG Research lowered STAAR Surgical from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 12th. Finally, William Blair downgraded STAAR Surgical from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $25.29.

Institutional Trading of STAAR Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the company. Victory Capital Management Inc. lifted its holdings in shares of STAAR Surgical by 16.7% in the 3rd quarter. Victory Capital Management Inc. now owns 189,481 shares of the medical instruments supplier’s stock worth $7,039,000 after acquiring an additional 27,143 shares during the last quarter. Quest Partners LLC purchased a new position in STAAR Surgical in the 3rd quarter worth $128,000. LMR Partners LLP lifted its stake in STAAR Surgical by 2.2% in the third quarter. LMR Partners LLP now owns 34,712 shares of the medical instruments supplier’s stock worth $1,290,000 after purchasing an additional 743 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in STAAR Surgical by 323.4% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 30,014 shares of the medical instruments supplier’s stock valued at $1,115,000 after buying an additional 22,925 shares during the period. Finally, Intech Investment Management LLC bought a new position in shares of STAAR Surgical during the third quarter valued at about $463,000. Hedge funds and other institutional investors own 96.70% of the company’s stock.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.